Lorlatinib and neurocognitive adverse events: characterization, risk factors, and the potentially mitigative role of social support
Supportive Care in Cancer · 2025
DOI: 10.1007/s00520-025-10182-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Supportive Care in Cancer, 2025. Verfasst von Ryan Brown und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Cleveland Clinic, Cleveland, OH, USA. Hauptthemen laut MEDLINE: Social Support, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Lactams, Macrocyclic. Die Arbeit nennt 26 Literaturangaben. Gefördert von: NIMHD NIH HHS, National Institute on Minority Health and Health Disparities.
Themen: Patientensicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Cleveland Clinic, Cleveland, OH, USA.
- Department of Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN, USA.
- Department of Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN, USA. jatoi.aminah@mayo.edu.
Förderung
- NIMHD NIH HHS
- National Institute on Minority Health and Health Disparities
Zitieren
APA
Brown, R., Smith, K. E., Shanshal, M. M., Dimou, A., Leventakos, K., Parikh, K., Mansfield, A. S., Molina, J. R., Goetz, M. P., Jatoi, A., & Cathcart-Rake, E. (2025). Lorlatinib and neurocognitive adverse events: characterization, risk factors, and the potentially mitigative role of social support. Supportive Care in Cancer. https://doi.org/10.1007/s00520-025-10182-9
Vancouver
Brown R, Smith KE, Shanshal MM, Dimou A, Leventakos K, Parikh K, et al. Lorlatinib and neurocognitive adverse events: characterization, risk factors, and the potentially mitigative role of social support. Supportive Care in Cancer. 2025. doi:10.1007/s00520-025-10182-9
BibTeX
@article{Brown2025,
author = {Brown, Ryan and Smith, Katie E and Shanshal, Mohamed M and Dimou, Anastasios and Leventakos, Konstantinos and Parikh, Kaushal and Mansfield, Aaron S and Molina, Julian R and Goetz, Matthew P and Jatoi, Aminah and Cathcart-Rake, Elizabeth},
title = {Lorlatinib and neurocognitive adverse events: characterization, risk factors, and the potentially mitigative role of social support},
journal = {Supportive Care in Cancer},
year = {2025},
doi = {10.1007/s00520-025-10182-9}
}
EUVIMED